Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Rhoden

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|January 14, 2022
Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparationsAlexandra Rhoden, Thomas Schulze, Niels Pietsch, et al.
Acta Physiologica (Oxford, England)|February 5, 2019
Preserved cardiovascular homeostasis despite blunted acetylcholine-induced dilation in mice with endothelial muscarinic M3 receptor deletionAlexandra Rhoden, Jakob Speiser, Birgit Geertz, et al.
ACS Pharmacology & Translational Science|December 18, 2025
Investigating the Anticancer Effects of Sulforaphane in an In Vitro Coculture Model of Prostate Cancer Cells with Engineered Heart TissueJane In den Birken, Laura Rathjens, Hannah Münch, et al.
Scientific Reports|December 5, 2019
Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissueAlexander Dutsch, Paul J M Wijnker, Saskia Schlossarek, et al.
Redox Biology|April 8, 2021
Sulforaphane exposure impairs contractility and mitochondrial function in three-dimensional engineered heart tissueAlexandra Rhoden, Felix W Friedrich, Theresa Brandt, et al.
Journal of Molecular and Cellular Cardiology|May 6, 2021
Translational investigation of electrophysiology in hypertrophic cardiomyopathyFrederik Flenner, Christiane Jungen, Nadine Küpker, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Physiology. Heart and Circulatory Physiology|January 14, 2022
Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparationsAlexandra Rhoden, Thomas Schulze, Niels Pietsch, et al.
Acta Physiologica (Oxford, England)|February 5, 2019
Preserved cardiovascular homeostasis despite blunted acetylcholine-induced dilation in mice with endothelial muscarinic M3 receptor deletionAlexandra Rhoden, Jakob Speiser, Birgit Geertz, et al.
ACS Pharmacology & Translational Science|December 18, 2025
Investigating the Anticancer Effects of Sulforaphane in an In Vitro Coculture Model of Prostate Cancer Cells with Engineered Heart TissueJane In den Birken, Laura Rathjens, Hannah Münch, et al.
Scientific Reports|December 5, 2019
Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissueAlexander Dutsch, Paul J M Wijnker, Saskia Schlossarek, et al.
Redox Biology|April 8, 2021
Sulforaphane exposure impairs contractility and mitochondrial function in three-dimensional engineered heart tissueAlexandra Rhoden, Felix W Friedrich, Theresa Brandt, et al.
Journal of Molecular and Cellular Cardiology|May 6, 2021
Translational investigation of electrophysiology in hypertrophic cardiomyopathyFrederik Flenner, Christiane Jungen, Nadine Küpker, et al.
Pageof 1